Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Minoxidil helps prevent hair loss from chemotherapy in rats.

HAC and BAC improve skin targeting and reduce diffusion without causing irritation.

A new compound shows promise as a topical treatment for hair loss.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

Erlotinib can cause hair loss and texture changes.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

A new therapy for a skin blistering condition has not been developed yet.

Biological therapy boosts the immune system to effectively fight melanoma.

Scalp cooling reduces hair loss and improves quality of life during chemotherapy.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

Baricitinib is effective and safe for treating severe alopecia areata.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Chromosomal microarray analysis is important for diagnosing rare genetic variations and guiding treatment.